Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06308055 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Abiomed Impella RT-DAQ - Observational Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Recruiting
    • Primary completion date: Jun 30, 2026 to Jun 30, 2027
    • Study sites: 5 to 4
    • Study completion date: Sep 30, 2026 to Dec 31, 2027
    v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 5 of 5 sites
    v4
  3. Primary completion date: Dec 1, 2025 to Jun 30, 2026
    • Study sites: 1 to 5
    • Study completion date: Mar 1, 2026 to Sep 30, 2026
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Apr 1, 2025 to Dec 1, 2025
    • Start date changed from estimate of Apr 1, 2024 to Oct 4, 2024
    • Study sites: 0 to 1
    • Study completion date: Apr 1, 2025 to Mar 1, 2026
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Abiomed Inc.
13 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition
Trial Details
NCT Number NCT06308055
Lead Sponsor Abiomed Inc.
Conditions
(from sponsor)		 Cardiogenic Shock
Related terms Shock, Cardiogenic
Enrollment 125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov